Abstract. Over the last 200 years humans experienced a huge increase of lifeexpectancy. These advances were largely driven by extrinsic improvements of their environment (for example, the available diet, disease prevalence, vaccination, and the state of hygiene and sanitation). In this paper we ask whether future improvements of life-expectancy will be bounded from above by human life-span. Life-span, in contrast to life-expectancy, is conceptualized as a biological measure of longevity driven by the intrinsic rate of bodily deterioration. In order to pursue our question we first present a modern theory of aging developed by bio-gerontologists and show that immutable life-span would put an upper limit on life-expectancy. We then show for a sample of developed countries that human life-span thus defined was indeed constant until the mid 20th century but increased since then in sync with life-expectancy. In other words, we find evidence for manufactured life-span.
Introduction
For economists human life-span is a given constant. It is the upper bound "T " that we put on top of the integral or sum sign when we compute expected life-time utility of a representative agent. Life-span differs conceptually from life-expectancy. Although we frequently treat lifeexpectancy, a measure, which depends on the probability to survive from one period to the next, as a constant as well, this is an assumption made "for convenience", since survival depends certainly on the macro-economic environment (GDP per capita, doctors per square kilometer etc) and on individual economic decisions (nutrition, health expenditure etc).
While most of economic theory is based on the simplifying assumptions of either certain survival until a given end of life or a given age-unrelated survival probability per time unit of life (based on Yaari, 1965, and Blanchard, 1985) there exists also a by now rich literature that tries to endogenize survival and to incorporate empirically plausible survival probabilities into economic reasoning. To the best of our knowledge, however, there exists no research in economics on human life-span.
1
With contrast to life-expectancy, which is population-specific and situation-specific, lifespan is usually conceptualized as a species-specific characteristic (Arking, 2006, Gavrilov and Gavrilova, 1991) . Life-expectancy of a population of mice, for example depends on the specific environment in the wild or in the laboratory. Life-span of mice, in contrast, is independent from such conditions but it differs from the life-span of fruitflies or elephants. Likewise, lifeexpectancy of a particular human population differs across countries (England vs. Uganda) and over time (England today vs. 200 years ago). Life-span of human beings, however, if it exists, should be invariant across populations. Probably all biologists agree to this notion of life-span.
But how to measure life-span is -in contrast to life-expectancy -less easily agreed upon.
Defining human life-span as the maximum attainable age at death, as suggested in many general dictionaries and many older contributions in biology is certainly misleading (Wilmoth, 1999 , Carey, 2003 . Conceptually this idea is refuted by the insight that "however old we are, our probability to die within the next hour is never equal to one" (Jacquard, 1982) . Empirically 1 For economic theory with realistic survival probabilities see, for example, Bütler (2001) , Boucekkine et al. (2002) , French (2005) Bloom, Canning, and Moore (2007) , Bullard and Feigenbaum (2007) , Hansen and Imrohoroglu (2008) , Romp (2008, 2009) , and Kalemli-Ozcan and Weil (2010) . A few economic papers, among them Ben Porath (1967) , Sunde and Cervellati (2005) , and Hazan (2009) , could be interpreted as studies on the economic impact of increasing life-span, although they rarely call it so and ignore its biological foundation. it has been refuted by the observation that maximum age at death has been continuously on the rise for at least 140 years (Wilmoth and Robine, 2003) .
The simple fact that the "sample size" of people who ever lived on earth is continuously rising lets us expect that the maximum ever-observed life-length will rise as time proceeds. This is impressively shown by Finch and Pike (1996) . They define life-span T as the estimated age at death of the last survivor of a population such that S(x) = 1/N is the probability to be the last man standing out of N . Plugging 1/N into an empirically estimated Gompertzian survival function they obtain a life-span of 105 years for N = 10 3 and 114 years for N = 10 7 . In general, the dependence of maxima on sample size is a well-known fact of the statistics of extreme values (Gumbel, 1958) .
From these observations it should be clear that life-span, in contrast to life-expectancy, cannot be defined as a mere statistical measure without biological foundation. We need some understanding about the biological mechanism of aging in order to infer an intrinsic mechanism that governs the pace at which our bodies deteriorate. Following standard reasoning in modern biology by taking aging and death as stochastic processes (Arking, 2006) , we are interested in whether a regularity exists which is common to all humans independently from environmental and genetic characteristics. From this regularity, if it exists, we try to infer life-span not as an absolute maximum but as the characteristic length of life.
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We begin our pursuit of human life-span in Section 2 by introducing two very strong empirical regularities, the Gompertz-Makeham law of mortality and the compensation effect of mortality. These empirical regularities are theoretically supported by reliability theory as shown by Gavrilov and Gavrilova (1991) and other bio-gerontologists. This led to the development of a novel theoretically founded conceptualization of human life-span. We sketch the essence of this theory and its consequences in Section 2.3. The most important quantitative implication is that human life-span can be inferred from the estimated compensation effect of mortality. In Section 3 we show that human life-span if it were immutable would lead to a rectangularization of the survival curve and thus would put an upper bound on future advances of human longevity.
2 Notice that our analysis at the population level cannot be generalized to population subgroups. Olshansky et al. (2012) , for example, document diverging trends in life expectancy by socio-economic status and race for the United States. In 2008, college educated white males lived more than 14 years longer than black males with less than high school education. For women this difference is still more than 10 years. Avendano et al. (2011) point out that highly educated Americans are relatively similar to Europeans in terms of life expectancy, while, the gap is quite large at lower education levels. One possible explanation for these stylized facts is different access to universal health care in Europe and the United States. Strulik (2011) proposes an explanation of the rising education gradient in an economic life cycle model with endogenous educational choice.
In Section 4 we estimate the parameters of the Gompertz-Makeham equation using the method of non-linear least squares and data on age-specific mortality rates from the Human Mortality Database. We then use the estimated parameters to analyze the compensation effect of mortality and infer human life-span. We observe a time-invariant compensating effect until the mid 20th century for all countries in our sample. For the second half of the 20th century we find evidence for a secular increase of human life-span. In other words we find that human ingenuity has effectively interfered with nature and has created "manufactured life-time" (Carnes and Olshansky, 2007) . Finally we show that life-expectancy in the second half of the last century increased in sync with life-span. To a large and increasing extent we are living longer because technological progress has changed the way we age and the way our bodies decay.
Our study continues the work of Strehler and Mildvan (1960) and Gavrilov and Gavrilova (1991) . Compared to these earlier works we used a larger sample consisting of more countries and covering a much longer period of time. This allowed us not only to confirm the earlier result of a time-invariant compensating effect (time invariant life span) until the mid 20th century but also, based on new data from the late 20th century, to derive the novel result of a secular increase of human life-span. This finding in turn allowed us to offer a novel explanation for the observation of "broken limits to life-expectancy" (Oeppen and Vaupel, 2002) : since about the 1970s later born humans can expect to live longer at least partly because human life span itself is on the rise. Let µ(x) denote the force of mortality, that is the conditional probability to die at age x given survival up to age x. The Gompertz law is then formally stated as µ(x) = R exp(αx). Noting that not all causes of death are age related, Makeham (1860) added a constant, A ≥ 0, which provides the famous Gompertz-Makeham formula.
Taking both simplicity and precision into account, the Gompertz-Makeham formula is to the present day the most appropriate, concise, and widely used formal description of aging (Olshansky and Carnes, 1997) . Its parameters are estimated with great precision with R 2 above 0.9 not only for humans but also for species as different as yeast, fruitflies, and horses. The estimated coefficients, of course, differ greatly, reflecting the large variation in life-span across species (Arking, 2006) .
Using the Gompertz-Makeham law and solvingṠ(x)/S(x) = −µ(x) we obtain the unconditional probability to survive to age x. Given that S(0) = 1 we arrive at (2).
From S(x) we can infer life-expectancy (expected remaining years to live) at age
Over the last century human life-expectancy at birth increased by more than 20 years in most of the fully developed countries (Riley, 2001) . It is interesting to investigate how these huge improvements of human longevity are captured by the Gompertz-Makeham law. For this purpose it is helpful to isolate the Makeham-parameter A because it reflects age-unrelated forces of mortality, i.e. background mortality (Bongaarts, 2005) or extrinsic mortality (Carnes and Oshansky, 2007) . We expect prevention, eradication, or cure of age-unrelated diseases to be reflected in changes of A. In contrast, any progress with respect to the aging process itself would be reflected in a change of the age-dependent Gompertz-parameters R and α. As can be seen from (1) and (2), a lower R would mean that humans start out in better health (in youth) and a lower α would mean that the speed of the aging process is slowed down. However, as shown in section 2.3, we expect that α and R do not change independently as long as human life-span is immutable.
Over the last two centuries background mortality went down dramatically in the today fully developed countries (for Sweden, for example, from 5.5·10 −3 to 4.810 −4 ; Gavrilov and Gavrilova, 1991) . With A being close to zero, future advances in life-expectancy will have to come from improvements of age-dependent mortality. In other words, if technological progress could affect only background mortality but not the intrinsic rate of bodily decay, the observed trend of improving life-expectancy at birth by about 3 month per year of birth (Oeppen and Vaupel, 2002) would not be sustainable in the future. Inspired by this fact some gerontologists have concluded that future life-expectancy at birth will unlikely exceed 85 years (Fries, 1980, Carnes and Olshansky, 2007) . The problem with such a hypothesis is that -although the virtually zero background mortality leaves no scope for improvement -we cannot (yet) see any slowdown or convergence of life-expectancy in the data (Wilmoth, 1997 (Wilmoth, , 1999 . This means that recent advances of life-expectancy must have originated from a process that is reflected by a change of the Gompertz parameters.
2.2. The Compensation Effect of Mortality. The Gompertz-parameters α and R, which are estimated with high precision for a given population, differ actually across sexes, across countries, and over time. This means that, while all humans seem to age according to a common general law of mortality, the specific parameters governing this law depend on sex, provenance, and time. Furthermore, R and α seem to depend also on geography and tend to fall (in the case of R) or rise (in the case of α) with economic development. Because of their instability the Gompertz-parameters as such are thus not suitable to identify human-life span.
[insert figure 1 here]
The Gompertz parameters, however, are not changing independently from each other but, strikingly, in a specific way such that they preserve an inverse association between α and the log of R. This fact is known as the Strehler-Mildvan correlation or the compensation effect of mortality (Strehler and Mildvan, 1960, Gavrilov and Gavrilova, 1991) . It is exemplarily shown for Sweden in Figure 1 and 2. Figure 1 shows the long-run trends for α and R. Over time, the slope parameter α tends to rise and the level parameter R tends to fall. This means that over time Swedish women tend to age at a faster speed but start out at lower initial mortality.
Below we show the generality of this phenomenon across countries and how it can be explained by increasing initial redundancy in the reliability theory of aging.
Formally, the compensation effect of mortality states that
in which R it and α it are the population-and year-specific parameters of the Gompertz law and M and T are invariant parameters of the compensation effect of mortality. Figure 2 shows the correlation for Swedish females and males.
To see how the compensation effect inspired a general theory of human aging insert (4) into country-and sex-specific age-dependent mortality
Observe that age-dependent mortality exhibits a fixed point. Equation (4) predicts that all men (and likewise all women) of a country's population share a common force of mortality M at age T independently from the year or century of birth. In other words, any improvement in the initial force of mortality µ 0 is compensated by a faster increase of µ x with age. The final step in the derivation of human life-span is to conclude that T is approximately constant across countries. This has been found by Gavrilov and Gavrilova (1991) for 209 human life-tables.
They thus interpret the focal point (T, M ) as a species-specific constant. For humans the point estimate was T = 95 years, identified by Gavrilov and Gavrilova as "the life-span of human beings".
[insert figure 2 here]
The difference between the Strehler-Mildvan correlation and the compensation effect is that Strehler and Mildvan (1960) in their original approach inferred the correlation from the Gompertz law, without the Makeham amendment. In order to infer life-span properly, however, the Gompertz parameters have to be derived from the Gompertz-Makeham law, with explicit consideration of background mortality A. Otherwise, results would be biased and changes in the extrinsic rate of mortality would be absorbed by the parameters governing the intrinsic rate of mortality. This has been demonstrated by Gavrilov and Gavrilova (1991) who called the unbiased correlation the "compensation effect of mortality". Controlling for A is of particular importance when background mortality is high, that is in the analysis of historical data and of contemporaneous less developed countries.
2.3. Reliability Theory. The strong regularities identified by Gompertz law and the compensation effect suggest that all humans share a common mechanism of aging, a common process according to which individual bodies lose function over time and bodily failures and impairments are accumulated. The pursuit to rationalize these phenomena has inspired an application of reliability theory, originally developed to study mechanical failures in engineering (Barlow and Proschan, 1975) , and produced the modern theory of aging (Arking, 2006) . Its main idea is based on redundancy within the human body which is depleted over time. This notion of aging as accelerated loss of organ reserve is in line with the mainstream view in the medical science.
For example, initially, as a young adult, the functional capacity of human organs is estimated to be tenfold higher than needed for survival. (Fries, 1980) . It accords also well with the modern view in biology, which conceptualizes aging and death as driven by accidental stochastic shocks on the molecular level (Arking, 2006) . Here we sketch a basic theory by Gavrilova (1991, 2001 ) and refer to their work as well as to Novoltsev (2006) Suppose an organism consists of m irreplaceable blocks, i.e. blocks connected in series such that the organism dies if one block fails. Each block consists of n elements, connected in parallel with age-independent failure rate λ. The probability for a block to expire before age x is given
Suppose that many elements are initially defect. The probability of an initially functioning element is given by q. It can then be shown that the failure rate of the organism (i.e. the mortality rate) is given by (5).
µ(x) ≈ Re α·x where
in which k ≡ nq is the mean number of initially functioning elements and c is a constant to provide a unitless result. The model thus explains Gompertz' law. Taking log's of R we get log R = log(cmkλ) − k and inserting α = kλ we arrive at log R = log M − αT , with M ≡ αmc and T ≡ 1/λ. The model thus explains the compensation effect of mortality.
For an interpretation of the result note that T is uniquely pinned down by λ, the ageindependent failure rate of an element. If λ is a species-specific constant, then the model supports a unique focal point T , i.e. a species-specific life-span. Across species, T depends inversely on the robustness of its non-aging elements. The compensation effect, according to this simple model of reliability, then means that any variation number of initially functioning elements, k = nq, is compensated by a proportional reduction of the number blocks m such that M stays constant.
Suppose that available nutrition (for mother and child) and disease exposure early in life have shaped k. Taking the historic improvement in nutrition and health into account, the model then predicts that with ongoing economic development people start out much better at young age but are aging faster. Consequently, survival prospects and life-expectancy have improved at any age up to age T .
In other words, a time-invariant compensation effect of mortality would imply that better health care and nutrition or, more generally, improvements of the economic environment through technological progress have increased life-expectancy "only" through improving somatic redundancy (for example, more healthy body cells; Fogel. 1994; Fogel and Costa, 1997) . In order to improve life-span T technological progress needs to have a bearing on λ, that is on the intrinsic rate of bodily decay.
Implications of Time-Invariant Human Life-Span

Compression of Morbidity. The notion of a constant life-span T is sometimes expressed
as "rectangularization" or as "compression of morbidity" (Fries, 1980) . These concepts are illustrated in Figure 3 . The left panel shows an improvement of the age-dependent force of aging according to the Strehler-Mildvan correlation. The slope parameter α increases from 0.08 (blue line) to 0.11 (red line). This is about the actually observed average increase for women during 20th century in our sample of countries. The level parameter R is assumed to adjusts in a way that supports a fixed point at T = 83.
The middle panel shows the implied unconditional survival rate S(x) and conveys the idea of rectangularization. Compared to the beginning of the century a higher share of women reaches an old age of, say 70 years, and expires then more quickly during their last years before death.
Visually, the survival curve becomes closer to rectangular over time. This implies that gains in life-expectancy, for example brought forward by technological progress in medicine, decrease with age as well, as demonstrated in the panel on the right hand side of Figure 3 . Improvements in health at earlier stages of life lead to a faster deterioration in old age, a compression of morbidity, such that women reaching an age of T share the same force of mortality at the beginning and at the end of the century.
[insert figure 3 here]
For comparison, Figure 4 shows the effect on survival and life-expectancy caused by an improving level parameter R without compensation effect. The slope parameter α is hold constant.
In this case the curves shift to the right at all ages, indicating that aging as such has been postponed at all ages and providing a visible increase of life-expectancy also for the old (see also Vaupel, 2010) . In terms of theory, the inherent failure rate of the elements of which humans are constructed λ has been manipulated. Human life-span T increased.
[insert figure 4 here] 3.2. The Future of Longevity. In this section we show that if the compensation effect of mortality is time-invariant and M and T are species-specific constants, then future gains of life-expectancy are bounded from above. This means that the notion of "broken limits to lifeexpectancy" (Oeppen and Vaupel, 2002) inferred from extrapolation of past trends would be ill-considered. Actually there would exist a certain limit to life-expectancy. In order to show this, we insert the compensation effect of mortality, R = M exp(−αT ), into (1). Assuming that A is zero (which is a reasonable approximation for contemporaneous fully developed countries)
we get the force of mortality µ = M exp[α(x − T )]. The implied survival at age x is S(x) = exp(y) exp [−M/α exp(α(x − T ))] with y ≡ M/α exp(−αT ). For analytical simplicity we focus on life-expectancy at birth, which is given by (6).
Substituting u = M/α exp [α(x − T )] into (6) provides the simplification (7).
in which Γ is the incomplete gamma function. Applying the mean value theorem of integral calculus we know that there exists a ξ with y < ξ < ∞ such that
Thus, L(0) = 1/(αξ), implying, since y < ξ < ∞ that L(0) < 1/(αy). Taking the derivative of life-expectancy with respect to life-span we obtain
because L(0) < 1/(αy). That is, life-expectancy and life-span are positively correlated. Analogously we obtain ∂L(0)/∂M < 0.
If the compensation effect of mortality is time-invariant and M and T are constants, the only way to improve life-expectancy is through α. In order to obtain the effect of α on L(0) we compute
The sign of the derivative is ambiguous and there exists an extremum for α = α * where ∂L/∂α = 0, that is at life-expectancy
After some algebra, the second derivative is obtained as
From this we conclude that the extremum is a maximum if
Since the slope of the exponential function is generally steeper than the slope of the quadratic, we conclude that for sufficiently large α there exists a maximum life-expectancy. This in turn means that life-expectancy is effectively bounded from above by life-span. Since y converges very rapidly to zero with rising α, we expect maximum life-expectancy to be about T + 1/α * .
[insert figure 5 here] Figure 5 visualizes these results for life-span T = 85. As the force of mortality α increases, the logarithm of initial mortality log R declines according to the compensation effect (3). This is shown by the dashed green line in Figure 5 , assuming that M = 0.26. Accordingly lifeexpectancy at birth increases steeply for small α and reaches an almost indiscernible maximum of 85.78 years at 1.27. Afterwards life-expectancy converges towards T from above (blue solid line). The panel on the right hand side demonstrates robustness of this result by -hypothetically -considering alternative survival rates M at age T . Noting that a perpetually increasing α under the compensation effect of mortality implies a rectangularization of the survival curve and that lim α→inf ty L(0) = T provides another definition of life-span: it is the maximum life-expectancy of a species under the compensation effect of mortality. This implies that that the observation of "broken limits to life-expectancy" (Oeppen and Vaubel, 2002 ) is actually inconsistent with a time-invariant compensation effect. In order to allow for "unlimited" life-expectancy, life-span of humans must be modifiable.
Empirical Evidence
In this section we use the established methodology and investigate whether human life-span is constant or modifiable. For that purpose we use data on 1 × 1 period death rates from the Human Mortality Database. 1 × 1 means that the data come for single years of age in one year time intervals. The Human Mortality Database contains detailed population and mortality data for 37 countries (there are multiple data series for France, Germany, New Zealand and the United Kingdom). The period of data coverage differs from country to country. For Sweden, for example, data is available way back to 1751, while for Chile data coverage starts only in 1992.
We confine our analysis to countries that have full data coverage from 1900 through 1999 (12 countries) or 1950 through 1999 (26 countries). This way we ensure a consistent sample and that our results are not due to changes in the sample composition. parameter. In the 1950-1999 sample, we lose one country-year observation due to an insignificant estimate of the R parameter for Finland. In the 1900-1999 sample, we lose 14 country-year observations due to insignificant estimates of the R parameter for Finland and New Zealand.
[insert table 2 here]
The parameter estimates for α and log(R) are reported in Tables 1 and 2 . For better visualization we break the data down into 25-year periods and report period averages. The overall trend shown in Section 2 for Sweden is clearly visible across all countries: α increases and R decreases over time. There are also interesting gender differences: α is higher for females than for males, whereas R is higher for males than for females. To simplify the exposition we have computed in the bottom line of Table 1 For females R decreased by more than one order of magnitude from exp(−9.14) = 1.07 · 10 −4 in 1900-24 to exp(−11.70) = 8.3 · 10 −6 in 1975-99. Again, the decrease is somewhat more modest for males. Summarizing, across all countries over the last century the trend shows that people become more healthy in young age but are aging faster as they get older. In a related study, Bongaarts (2005) estimates the parameters of the Gompertz law for 14 countries in the period 1950-2000 and finds a "nearly constant" slope parameter (α in our notation) and a secularly falling level parameter (R in our notation). It is tempting to conclude from Bongaarts' finding of decreasing R that human life-span has risen over the last half of the 20th century. On a closer look, however, this evidence is insufficient for a conclusion on human life span. Firstly, α and R are not species-specific parameters, they vary across countries and sexes. Secondly, it is misleading to compare α and R at the same (absolute) scale. Inspection of (1) shows that a unit change of α contributes as much to the force of mortality as a unit change of the logarithm of R.
4.2. Survival Probability. We next use the average parameters of the Gompertz equation to compute the unconditional probability to survive to age x. Figure 6 shows the survival functions for average females and males in 1900-24 (solid lines) and 1975-99 (dashed lines) . Two salient phenomena can be observed. First, a rectangularization or compression of morbidity is clearly visible. In 1900-24 the decline of the survival probability starts already around age 20 whereas in 1975-99 survival probability stays close to unity until around age 40 and then declines more rapidly than in the first quarter of the century. Second, in addition to the rectangularization of the survival function, we observe also that the survival function shifts to the right from period 1900-24 to 1975-99 . The right shift is not uniform across all ages, but clearly very old people are benefitting from improved survival probabilities as well.
As explained in Section 2 this finding is inconsistent with a time-invariant compensation effect of mortality. It is a first indication that human life span might be modifiable.
[insert figure 6 here]
In Figure A .2 in the appendix we redo the analysis country by country. We take the period 
β 1 represents the negative life span −T and β 0 represents log(M ), the mortality rate shared by all humans of age T . Exploratory data analysis in Figure A .3 in the appendix suggests that the slope coefficient T indeed changes over time. Pooling the observations over a too long period 4 Yashin et al. (2001) arrive at a similar conclusion using period and cohort data for a smaller sample of countries (France, Japan, Sweden and the US).
would lead to misleading results. We thus focus on the 26 countries, for which we have a full data from 1950-1999, and estimate equation (11) with pooled OLS for 1950-74 and 1975-1999 respectively. The result is visualized in Figure 7 . Red circles identify data points in the 1950-74 period and blue circles reflect the 1975-99 period. It is clearly visible that in the later period an improvement of log(R) was associated with a somewhat smaller increase of α than in the earlier period, implying that the slope -representing human life span -increased in absolute value during the 20th century.
[insert figure 7 here] Expanding life-span, however is a fairly recent phenomenon. Extending the sample period over the whole last century provides supporting evidence for the notion of invariant life-span during the first half of the century. As shown in Table 4 Since their sample contained many less developed countries, the bias incurred from ignoring background mortality was potentially large (see Gavrilov and Gavrilova, 1991) . This potential bias may explain why they arrived at a much higher estimate of life-span (referred to as the age of zero vitality according to the Strehler-Mildvan methodology) for a sample containing many developing countries than we do for a sample of fully developed countries.
nutrition, e.g. Fogel and Costa, 1997) . Then, in the later 20th century, "something" happened.
According to reliability theory these events effectively manipulated the failure rate, that is the intrinsic rate of bodily decay.
[insert Oeppen and Vaupel (2002) . 6 We visualize the combined data in Figure The notion of an expanding human life-span is helpful to rationalize why other researchers have not (yet) observed any convergence of increasing life-expectancy (Wilmoth, 1997 , Vaupel, 2010 ). Predictions of a certain limit to life-expectancy -for example, that it should not exceed 35 years at age of 50 (Olshansky et al, 1990 ) -are presumably made under the wrong perception of an invariant human life-span, in which case they would have been indeed fully justified and understandable as the analysis in Section 3.2 has shown. Unlike other species, however, humans seem to be able to modify life-span such that there is no limit of life-expectancy visible in the data.
Conclusions
In this paper we have introduced to the economics science a theoretical foundation of human life-span based on two strong empirical regularities, the Gompertz-Makeham law and the compensation effect of mortality. We have estimated the parameters of the Gompertz-Makeham model and found a remarkable long-run trend. Contemporaneous humans start out as young adults much more healthy than their forefathers a century ago but they are also aging faster. For a long time of our history this trend was consistent with the observation of rising life-expectancy under an invariant life-span.
If life-span were indeed immutable, as it is presumably for other animals, future improvements in life-expectancy would soon end. Life expectancy, as we have shown in this paper, is bounded from above by life-span. For the second half of the 20th century, however, we were able to present evidence for expanding life-span. It increased by about 8 years. For the last quarter of the 20th century we find furthermore that life-expectancy increased in sync with lifeexpectancy, a phenomenon that explains why other researchers have observed "broken limits to life-expectancy" (Oeppen and Vaupel, 2002) .
It is beyond the scope of the present paper to identify the cause of expanding life-span. Yet theory suggests that the potential candidates have to be fairly recent events which manipulated the failure rate of human body parts. The most natural candidates are probably regenerative medicine and replacement surgery. To be more concrete, heart bypass operation and dialysis machines are two prominent examples of medical innovations of the second half of the 20th century which prolonged human lifes by replacing the functional performance of failed organs.
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The notion of modifiable life-span is important for economists, policymakers as well as theorists. Taking the "capital T " as constant may lead to severe misjudgments about the future of population aging and the financial stability, meaningfulness, and efficiency of social security and public health systems. Also, on the individual level, the awareness of modifiable and potentially further rising life-span beyond the "natural" improvements of life-expectancy, may have quite dramatic effects on life-cycle decisions like schooling, savings, and retirement. Re-considering the 7 As discussed in the introduction, our findings at the population level cannot be generalized to all subgroups of the population. Whether or not an individual benefits from the advancements in health technology (such as replacement surgery) depends on many different factors, such as the socio economic status of the individual or the inclusiveness of the health system.
conventional life-cycle theory and integrating the notion of expanding life-span is a challenging task for future research.
